State Board of Administration of Florida Retirement System’s Iovance Biotherapeutics IOVA Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$272K	Hold	65,451	–	–	﹤0.01%	1869
2026 Q1	$230K	Hold	65,451	–	–	﹤0.01%	1822
2025 Q4	$179K	Hold	65,451	–	–	﹤0.01%	1923
2025 Q3	$142K	Hold	65,451	–	–	﹤0.01%	1989
2025 Q2	$113K	Hold	65,451	–	–	﹤0.01%	2028
2025 Q1	$218K	Hold	65,451	–	–	﹤0.01%	1844
2024 Q4	$484K	Hold	65,451	–	–	﹤0.01%	1547
2024 Q3	$615K	Hold	65,451	–	–	﹤0.01%	1459
2024 Q2	$525K	Buy	65,451 +17,140	+35%	+$184K	﹤0.01%	1496
2024 Q1	$295K	Sell	48,311 -17,140	-26%	-$199K	﹤0.01%	1774
2023 Q4	$532K	Hold	65,451	–	–	﹤0.01%	1572
2023 Q3	$298K	Buy	65,451 +6,390	+11%	+$41.7K	﹤0.01%	1842
2023 Q2	$416K	Buy	59,061 +10,750	+22%	+$76.9K	﹤0.01%	1684
2023 Q1	$295K	Hold	48,311	–	–	﹤0.01%	1844
2022 Q4	$309K	Sell	48,311 -5,820	-11%	-$45.4K	﹤0.01%	1841
2022 Q3	$519K	Hold	54,131	–	–	﹤0.01%	1568
2022 Q2	$598K	Sell	54,131 -155,471	-74%	-$2.04M	﹤0.01%	1553
2022 Q1	$3.49M	Buy	209,602 +153	+0.1%	+$2.37K	0.01%	933
2021 Q4	$4M	Buy	209,449 +321	+0.2%	+$7.07K	0.01%	925
2021 Q3	$5.16M	Sell	209,128 -5,398	-3%	-$127K	0.01%	875
2021 Q2	$5.58M	Buy	214,526 +50,388	+31%	+$1.31M	0.01%	872
2021 Q1	$5.2M	Sell	164,138 -2,480	-1%	-$103K	0.01%	871
2020 Q4	$7.73M	Buy	166,618 +813	+0.5%	+$32.3K	0.02%	730
2020 Q3	$5.46M	Buy	165,805 +1,770	+1%	+$54.3K	0.01%	766
2020 Q2	$4.5M	Buy	164,035 +114,963	+234%	+$3.78M	0.01%	813
2020 Q1	$1.47M	Buy	49,072 +8,090	+20%	+$214K	﹤0.01%	1041
2019 Q4	$1.13M	Buy	40,982 +2,670	+7%	+$60.7K	﹤0.01%	1320
2019 Q3	$697K	Hold	38,312	–	–	﹤0.01%	1533
2019 Q2	$939K	Buy	38,312 +6,050	+19%	+$91.1K	﹤0.01%	1419
2019 Q1	$307K	Hold	32,262	–	–	﹤0.01%	1975
2018 Q4	$286K	Buy	32,262 +3,650	+13%	+$35.2K	﹤0.01%	1984
2018 Q3	$322K	Buy	28,612 +5,320	+23%	+$75.5K	﹤0.01%	2058
2018 Q2	$298K	Buy	23,292 +8,660	+59%	+$127K	﹤0.01%	2104
2018 Q1	$247K	Buy	+14,632	New	+$222K	﹤0.01%	2156

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

State Board of Administration of Florida Retirement System's IOVA Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 65,451 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

State Board of Administration of Florida Retirement System first reported a position in IOVA in Q1 2018 and has held it in 34 quarters since. The position peaked at $7.73M in Q4 2020. 120 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

State Board of Administration of Florida Retirement System held 65,451 shares of Iovance Biotherapeutics worth $272K as of Q2 2026.
State Board of Administration of Florida Retirement System left its Iovance Biotherapeutics share count unchanged in Q2 2026.
Iovance Biotherapeutics made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1869 holding.
State Board of Administration of Florida Retirement System first reported a position in Iovance Biotherapeutics in Q1 2018 and has held it in 34 quarters since.
State Board of Administration of Florida Retirement System's Iovance Biotherapeutics position peaked at $7.73M in Q4 2020.
120 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.